DrugPatentWatch Database Preview
Details for Patent: 9,579,270
Email this page to a colleague
See Plans and PricingWhich drugs does patent 9,579,270 protect, and when does it expire?
Patent 9,579,270 protects LATISSE and is included in one NDA.
This patent has seventeen patent family members in nine countries.
Summary for Patent: 9,579,270
| Title: | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| Abstract: | A method for treating hair loss in mammals uses compositions containing prostaglandin F analogs. The compositions can be applied topically to the skin. The compositions can arrest hair loss, reverse hair loss, and promote hair growth. |
| Inventor(s): | deLong; Mitchell A. (Chapel Hill, NC), McIver; John M. (Cincinnati, OH), Youngquist; Robert S. (Mason, OH) |
| Assignee: | Duke University (Durham, NC) |
| Application Number: | 14/958,334 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,579,270 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 9,579,270
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | LATISSE | bimatoprost | SOLUTION/DROPS;TOPICAL | 022369-001 | Dec 24, 2008 | AT | RX | Yes | Yes | Start Trial | Start Trial | METHOD OF INCREASING EYELASH GROWTH WITH BIMATOPROST | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,579,270
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 309775 | Start Trial | |||
| Australia | 5303901 | Start Trial | |||
| Canada | 2401731 | Start Trial | |||
| China | 100384425 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
